Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

£40m boost for UK life sciences

£40m boost for UK life sciences

INTERVIEW: PT talks diabetes with AZ' Chris Boulton

INTERVIEW: PT talks diabetes with AZ' Chris Boulton

Sun completes $4bn Ranbaxy merger

Sun completes $4bn Ranbaxy merger

FDA OK for Sanofi's Quadracel vaccine

FDA OK for Sanofi's Quadracel vaccine

Fourth US OK for Regeneron's Eylea

Fourth US OK for Regeneron's Eylea

AZ teams up with Harvard in diabetes pact

AZ teams up with Harvard in diabetes pact

UK launch for Janssen's Velcade for MCL

UK launch for Janssen's Velcade for MCL

CR UK ties with EPSRC for collaborative research

CR UK ties with EPSRC for collaborative research

NICE rules on Celgene's Imnovid, BI's Jardiance, Norgine's Targaxan

NICE rules on Celgene's Imnovid, BI's Jardiance, Norgine's Targaxan

Therapeutic focus – Cell therapies await real answers in ALS

The repeated failure of small molecules to make any impact in the fatal neuro-degenerative condition amyotrophic lateral sclerosis (ALS) means much hope is being placed in stem cell-based...
more news